How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

Got a confidential news tip? We want to hear from you. Sign up for free newsletters and get more CNBC delivered to your inbox Get this delivered to your inbox, and ...

The fund sparked swift legal challenges and political uproar, including from Senate Republicans, who expressed anger that people who attacked the U.S. Capitol on January 6, 2021, could receive ...

“The Scent of Swing: Jazz, Fragrance, and the Invisible Aura of Cool” is an evocative, cross-sensory exploration of how jazz—long understood as a sonic art form rooted in rhythm, improvisation, and ...

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.